Literature DB >> 9363927

Serum levels of eosinophil cationic protein and IL-5 in patients with asthma without systemic corticosteroids.

S Motojima1, K Tateishi, T Koseki, S Makino, T Fukuda.   

Abstract

We measured the serum levels of eosinophil cationic protein (ECP) and interleukin-5 (IL-5) in 39 patients with asthma (symptomatic 12, asymtomatic 27) without systemic corticosteroids and 49 healthy subjects. There were significant differences in serum levels in both ECP and IL-5 between symptomatic and asymptomatic asthma, and healthy subjects. A significant positive correlation was found between serum levels of ECP and IL-5. No significant correlation was found between %FEV1 and serum level of ECP or IL-5, however, when the analysis was restricted to patients of less than 60 years of age, the correlations were significant. These results suggest that IL-5 is one of the factors that activate eosinophils even in peripheral blood, and that measurement of serum levels of ECP and IL-5 is useful for in vitro monitoring of asthma.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9363927     DOI: 10.1159/000237719

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  3 in total

1.  Effect of oral glucocorticoid treatment on serum inflammatory markers in acute asthma.

Authors:  A Sahid El-Radhi; C L Hogg; J K Bungre; A Bush; C J Corrigan
Journal:  Arch Dis Child       Date:  2000-08       Impact factor: 3.791

2.  The efficacy of a comprehensive lifestyle modification programme based on yoga in the management of bronchial asthma: a randomized controlled trial.

Authors:  Ramaprabhu Vempati; Ramesh Lal Bijlani; Kishore Kumar Deepak
Journal:  BMC Pulm Med       Date:  2009-07-30       Impact factor: 3.317

3.  The predictive value of eosinophil cationic protein and lactate dehydrogenase in asthma: a comparative study of serum versus sputum.

Authors:  Amina Hamed Ahmad Al Obaidi; Abdul Ghani Mohamed Al Samarai; Jasim Al-Janabi; Abdulkareem Yahia
Journal:  World Allergy Organ J       Date:  2009-07       Impact factor: 4.084

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.